Teva fine sees EU break new antitrust ground on patents, disparagement
Teva Pharmaceuticals today bore the brunt of the EU's latest antitrust clampdown in the pharma sector, seeing sanctions for two new breeds of conduct: patent game-playing and trash-talking rivals. While the...To view the full article, register now.
Already a subscriber? Click here to view full article